Curebase Secures $40 Million in Series B Funding

Industry Ventures leads investment round in technology-driven clinical trial startup SAN FRANCISCO, May 5, 2022 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, has raised $40 million in Series B funding to continue development of its end-to-end...

Click to view original post